HK Stock Market Move | BEAUTYFARM MED (02373) rose over 5%, with adjusted net profit in the first half of the year increasing by 40% year-on-year. The performance of the three major business segments is impressive.
Beautiful Countryside Medical Health (02373) surged over 5%. As of the time of this report, it rose by 5.43%, reaching HK$19.04, with a transaction volume of HK$4.5684 million.
BEAUTYFARM MED (02373) has risen over 5%, and as of the time of this report, it has increased by 5.43%, reaching HKD 19.04, with a transaction volume of HKD 4.5684 million.
On the news front, on August 28, BEAUTYFARM MED released its mid-year performance report for 2026. In the first half of this year, the company reported operating revenue of RMB 1.88 billion, a year-on-year increase of 29%; net profit of RMB 240 million, a year-on-year surge of 40%; adjusted net profit of RMB 260 million, a year-on-year increase of 40%; and a gross margin of 51.4%, up 2 percentage points year-on-year.
In the first half of the year, the beauty and health services generated revenue of RMB 1.09 billion, a year-on-year increase of 35.7%; gross margin at 44.2%, an increase of 2.1 percentage points year-on-year. The significant growth in performance is attributed to a simultaneous increase in volume and price on the consumption side at stores. Medical beauty services achieved better-than-expected growth, generating revenue of RMB 603 million, a year-on-year increase of 20.9%, with foot traffic reaching 61,000 people, a year-on-year increase of 23.7%, and a 3.9% year-on-year increase in average spending per customer, achieving simultaneous growth in both volume and price. In the sub-health sector, in the first half of the year, sub-health medical services provided by Yuanyuan Health generated revenue of RMB 180 million, a year-on-year increase of 20%.
Related Articles

HK Stock Market Move | CIRRUS (02507) rose nearly 6% again, with aircraft deliveries continuing to increase. The net profit for the first half of the year grew by more than 35% year-on-year.

Morgan Stanley: Downgrade Bilibili, Inc. Sponsored ADR Class Z (BILI.US) target price to $27, reiterate "Overweight" rating.

Morgan Stanley: Raised the target price for WuXi AppTec (02359) to HKD 220 and reiterated the "Overweight" rating.
HK Stock Market Move | CIRRUS (02507) rose nearly 6% again, with aircraft deliveries continuing to increase. The net profit for the first half of the year grew by more than 35% year-on-year.

Morgan Stanley: Downgrade Bilibili, Inc. Sponsored ADR Class Z (BILI.US) target price to $27, reiterate "Overweight" rating.

Morgan Stanley: Raised the target price for WuXi AppTec (02359) to HKD 220 and reiterated the "Overweight" rating.

RECOMMEND





